The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of a recurrent ventral incisional hernia.
It was reported that after implant, the patient experienced recurrence, wound dehiscence with evisceration, grossly distended abdomen, drainage from skin incision, bowel nearly protruding through skin incision, light fibrinous inflammatory adhesions, extensive gaseous distended ileus, sepsis, respiratory failure, purulent material in subcutaneous space, fibrinous adhesions, abdominal bloating, nausea, vomiting, non-healing wound on abdomen, bowel obstruction, dehydration, acute renal failure, leukocytosis, and multiple hospitalizations.
Post-operative patient treatment included revision surgeries, lysis of adhesions, exploratory laparotomy, and mesh removal.
|